T cell immunity and graft-versus-host disease (GVHD)

Autoimmunity Reviews

Volumn 5, Issue 1, 2006, Pages 1-9

  Ichiki, Yasunori ^a   Bowlus, Christopher L ^b   Shimoda, Shinji ^c   Ishibashi, Hiromi ^d   Vierling, John M ^e   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KYUSHU UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allogeneic bone marrow transplantation; Autoantibodies; Graft versus host disease; Major histocompatibility complex

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; CYTOTOXIC FACTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

AIRWAY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BILE DUCT; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL INFILTRATION; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE SEVERITY; EPITOPE MAPPING; GASTROINTESTINAL TRACT; GRAFT VERSUS HOST REACTION; HAIR FOLLICLE; HLA SYSTEM; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE; LIVER; MAJOR HISTOCOMPATIBILITY COMPLEX; MORBIDITY; MORTALITY; MUCOSA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SKIN; T LYMPHOCYTE ACTIVATION;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; MINOR HISTOCOMPATIBILITY ANTIGENS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 28744453704     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.02.006     Document Type: Review

References (39)

1. A.M. Dickinson, X.N. Wang, and L. Sviland In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens Nat Med 8 2002 410 414
2. J. Norton, N. al-Saffar, and J.P. Sloane Adhesion molecule expression in human hepatic graft-versus-host disease Bone Marrow Transplant 10 1992 153 156
3. H. Goker, I.C. Haznedaroglu, and N.J. Chao Acute graft-vs-host disease: pathobiology and management Exp Hematol 29 2001 259 277
4. Y. Kataoka, T. Iwasaki, and T. Kuroiwa The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease Immunology 103 2001 310 318
5. + T lymphocytes Blood 103 2004 4216 4221
6. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 2002 389 399
7. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 9 2003 1144 1150
8. E. Simpson, D. Scott, and E. James Minor H antigens: genes and peptides Transpl Immunol 10 2002 115 123
9. + T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens Biol Blood Marrow Transplant 10 2004 91 105
10. + T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation Bone Marrow Transplant 21 1998 583 590
11. M. Murata, E.H. Warren, and S.R. Riddell A human minor histocompatibility antigen resulting from differential expression due to a gene deletion J Exp Med 197 2003 1279 1289
12. + T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate Biol Blood Marrow Transplant 7 2001 2 13
13. M. Hirokawa, T. Matsutani, and H. Saitoh Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation Bone Marrow Transplant 30 2002 915 923
14. M.B. Bruley Rosset, V. Tieng, D. Charron, and A. Toubert Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice Clin Exp Immunol 132 2003 46 52
15. X.Z. Yu, S.J. Bidwell, P.J. Martin, and C. Anasetti CD28-specific antibody prevents graft-versus-host disease in mice J Immunol 164 2000 4564 4568
16. X.Z. Yu, M.H. Albert, P.J. Martin, and C. Anasetti CD28 ligation induces transplantation tolerance by IFN-γ-dependent depletion of T cells that recognize alloantigens J Clin Invest 113 2004 1624 1630
17. U.A. Duffner, Y. Maeda, and K.R. Cooke Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease J Immunol 172 2004 7393 7398
18. M. Merad, P. Hoffmann, and E. Ranheim Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease Nat Med 10 2004 510 517 [Erratum Nat Med 10, 649]
19. + T cell-mediated graft-versus-host disease model J Clin Invest 112 2003 1880 1886
20. W.D. Shlomchik, M.S. Couzens, and C.B. Tang Prevention of graft versus host disease by inactivation of host antigen-presenting cells Science 285 1999 412 415
21. T. Teshima, R. Ordemann, and P. Reddy Acute graft-versus-host disease does not require alloantigen expression on host epithelium Nat Med 8 2002 575 581
22. + T cell-mediated graft-versus-host disease: effects of conditioning Biol Blood Marrow Transplant 6 2000 604 612
23. K.P. MacDonald, V. Rowe, and C. Filippich Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation Biol Blood Marrow Transplant 10 2004 373 385
24. B. Nikolic, S. Lee, R.T. Bronson, M.J. Grusby, and M. Sykes Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets J Clin Invest 105 2000 1289 1298
25. J.Y. New, B. Li, and W.P. Koh T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease Bone Marrow Transplant 29 2002 979 986
26. + T cells to the liver, lung, and spleen during graft-versus-host disease Blood 96 2000 2973 2980
27. L.A. Welniak, Z. Wang, and K. Sun An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease Exp Hematol 32 2004 318 324
28. + T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease J Clin Invest 104 1999 49 57
29. C.A. Wysocki, S.B. Burkett, and A. Panoskaltsis-Mortari Differential roles for CCR5 expression on donor T Cells during graft-versus-host disease based on pretransplant conditioning J Immunol 173 2004 845 854
30. U. Duffner, B. Lu, and G.C. Hildebrandt Role of CXCR3-induced donor T-cell migration in acute GVHD Exp Hematol 31 2003 897 902
31. K. Miwa, H. Hashimoto, T. Yatomi, N. Nakamura, S. Nagata, and T. Suda Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease Int Immunol 11 1999 925 931
32. Z. Jiang, E. Podack, and R.B. Levy Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis Blood 98 2001 390 397
33. L. Marks, N.H. Altman, E.R. Podack, and R.B. Levy Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients Transplantation 77 2004 804 812
34. Y. Ueno, M. Ishii, and K. Yahagi Fas-mediated cholangiopathy in the murine model of graft versus host disease Hepatology 31 2000 966 974
35. K. Hattori, T. Hirano, and H. Miyajima Differential effects of anti-Fas ligand and anti-tumor necrosis factor a antibodies on acute graft-versus-host disease pathologies Blood 91 1998 4051 4055
36. M.R. van den Brink, E. Moore, and K.J. Horndasch Fas-deficient lpr mice are more susceptible to graft-versus-host disease J Immunol 164 2000 469 480
37. C. Schmaltz, O. Alpdogan, and S.J. Muriglan Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation Blood 101 2003 2440 2445
38. T. Ichiba, T. Teshima, and R. Kuick Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays Blood 102 2003 763 771
39. A. Panoskaltsis-Mortari, J.R. Hermanson, I.Y. Haddad, O.D. Wangensteen, and B.R. Blazar Intercellular adhesion molecule-I (ICAM-I, CD54) deficiency segregates the unique pathophysiological requirements for generating idiopathic pneumonia syndrome (IPS) versus graft-versus-host disease following allogeneic murine bone marrow transplantation Biol Blood Marrow Transplant 7 2001 368 377